Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs …

Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review

BE Thomas, P Shanmugam, M Malaisamy, S Ovung… - PloS one, 2016 - journals.plos.org
Background Limited treatment options, long duration of treatment and associated toxicity
adversely impact the physical and mental well-being of multidrug-resistant tuberculosis …

Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

Z Lan, N Ahmad, P Baghaei, L Barkane… - The Lancet …, 2020 - thelancet.com
Background Treatment of multidrug-resistant tuberculosis requires long-term therapy with a
combination of multiple second-line drugs. These drugs are associated with numerous …

Adverse drug reactions in tuberculosis and management

R Prasad, A Singh, N Gupta - Indian Journal of Tuberculosis, 2019 - Elsevier
Background Treatment of drug susceptible tuberculosis (DS-TB) requires regimens
containing first line drugs (FLDs') whereas drug resistant tuberculosis (DR-TB) are treated …

A review of the interplay between tuberculosis and mental health

AM Doherty, J Kelly, C McDonald, AM O'Dywer… - General hospital …, 2013 - Elsevier
AIMS: Tuberculosis and mental illness share common risk factors including homelessness,
HIV positive serology, alcohol/substance abuse and migrant status leading to frequent …

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement

J Domínguez, EC Boettger, D Cirillo… - … of tuberculosis and …, 2016 - ingentaconnect.com
The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to
global tuberculosis (TB) control. Although culture-based methods have been regarded as …

Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression

G Cáceres, R Calderon… - Therapeutic Advances in …, 2022 - journals.sagepub.com
Tuberculosis is one of the leading causes of death worldwide, primarily affecting low-and
middle income countries and individuals with limited-resources within fractured health care …

Adverse events associated with the treatment of multidrug-resistant tuberculosis: a systematic review and meta-analysis

S Wu, Y Zhang, F Sun, M Chen, L Zhou… - American journal of …, 2016 - journals.lww.com
Multidrug-resistant tuberculosis (MDR-TB) is a growing public health problem. Due to long
duration of therapy and concurrent use of multiple second-line drugs, adverse drug events …

Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis

TJ Hwang, DF Wares, A Jafarov… - … of tuberculosis and …, 2013 - ingentaconnect.com
Although cycloserine (CS) is recommended by the World Health Organization as a second-
line agent for the treatment of multidrug-resistant tuberculosis (MDR-TB), safety concerns …

Assessment of adverse drug events, their risk factors, and management among patients treated for multidrug-resistant TB: A prospective cohort study from Pakistan

FU Khan, A Khan, FU Khan, K Hayat… - Frontiers in …, 2022 - frontiersin.org
Background: Multidrug-resistant tuberculosis (MDR-TB) is a growing public health problem.
Treatment regimens used against MDR-TB are costly, prolonged, and associated with more …